What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
June, 14 2025
The #I3LUNG partners Dr. Helena Linardou, Arsela Prelaj, and Marina Chiara Garassino proudly opened the Summer School on AI in […]
News
Press release
June, 13 2025
For the third consecutive year, the 16 partners of the I3LUNG consortium, an EU-funded project under the Horizon 2020 programme, […]
News
June, 13 2025
This year’s meeting has been packed with bold ideas 💡, honest debates 🗣️, and collaborative energy 🤝, all driving us toward a stronger, […]